Document is current
Any future updates will be listed below
-
Authors
Egeland, Eivind Valen https://orcid.org/0000-0002-7273-7277
Seip, Kotryna https://orcid.org/0000-0001-5936-7294
Skourti, Eleni
Øy, Geir Frode
Pettersen, Solveig J.
Pandya, Abhilash D. https://orcid.org/0000-0002-7713-3050
Dahle, Maria A.
Haugen, Mads H.
Kristian, Alexander
Nakken, Sigve https://orcid.org/0000-0001-8468-2050
Engebraaten, Olav
Mælandsmo, Gunhild M.
Prasmickaite, Lina
- License Information
-
More Information
Article History
Received: 10 May 2024
Revised: 26 September 2024
Accepted: 2 October 2024
First Online: 10 October 2024
Competing interests
: Dr O Engebraaten receives institutional research support from AstraZeneca. Dr A Kristian is currently an employee at Novartis. All other authors have no conflict of interest to report.
: Ethical approvals for the studies involving animals (FOTSid 10296, 12097/28802 and 15499) were given by the Norwegian Food Safety Authority. All experiments involving animals were carried out in accordance with institutional guidelines, national legislation, and the European Union Directive 2010/63/EU.
